Latest Share Chat

Oxford Biomedica Share News (OXB)

Oxford Biomedica Information

Buy OXB Shares
Add OXB to Watchlist
Add OXB to Alert

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 311.50

Bid: 311.00

Ask: 313.50

Change: -3.50 (-1.11%)

Spread: 2.50 (0.804%)

Open: 320.00

High: 320.00

Low: 306.50

Prev. Close: 315.00

Last checked at -

Oxford Biomedica says Sanofi pulling out of haemophilia project

Fri, 19th Mar 2021 07:50

(Sharecast News) - Oxford Biomedica said that Sanofi's decision to terminate collaboration on a haemophilia treatment would have a "negligible" impact on revenue.
Sanofi had given notice to "terminate the collaboration and license agreement for process development and manufacturing of lentiviral vectors to treat haemophilia", Oxford said on Friday.

"The group expects that the impact on revenue will be negligible over the coming 24 month period."

More News

14 May 2020 09:19

UK BROKER RATINGS SUMMARY: Berenberg Raises HSBC To Hold From Sell

6 May 2020 15:07

Oxford Biomedica Sinks To Loss In 2019 But Remains Optimistic

6 May 2020 12:52

Oxford Biomedica swings to loss as licensing revenue falls

(Sharecast News) - Gene and cell therapy company Oxford Biomedica reported an improvement in bioprocessing and commercial development revenues to ?47.3m in its preliminary results on Wednesday, from ?40.5m.

29 Apr 2020 16:13

UK Earnings, Trading Statements Calendar - Next 7 Days

28 Apr 2020 11:13

Liberum hikes target price on Oxford Biomedica

(Sharecast News) - Analysts at Liberum hiked their target price on gene and cell therapy company Oxford BioMedica from £8.60 per share to £10.90 on Tuesday, citing demand at its new OxBox manufacturing facility.

8 Apr 2020 16:13

Oxford Biomedica joins Covid-19 vaccine consortium

(Sharecast News) - Gene and cell therapy company Oxford Biomedica has joined a consortium led by the Jenner Institute at Oxford University, it announced on Wednesday, to rapidly develop, scale-up and manufacture a potential vaccine candidate for Covid-19, called 'ChAdOx1 nCov-19'.

8 Apr 2020 14:46

UK TRADING UPDATE SUMMARY: Novacyt Gets WHO Covid-19 Test Kit Okay

20 Mar 2020 15:57

DIRECTOR DEALINGS SUMMARY: Plus500 Team Spend GBP14 Million On Shares

19 Mar 2020 10:59

Oxford Biomedica Expects 2019 Loss As Chair Steps Down, Signs New Deal

4 Feb 2020 12:10

Oxford Biomedica Sells USD8.4 Million In Orchard Therapeutics Shares

19 Dec 2019 16:27

Oxford Biomedica Extends Agreement With Novartis By Five Years

30 Sep 2019 09:55

BROKER RATINGS SUMMARY: Barclays Cuts Whitbread And Raises SSE

28 May 2019 13:18

Novo Holdings pours ?53.5m into Oxford Biomedica

(Sharecast News) - Gene and cell therapy company Oxford Biomedica announced on Tuesday that Novo Holdings has agreed to invest up to £53.5m in the group, in return for new ordinary shares representing up to 10.1% of the outstanding shares after the capital increase.

15 Mar 2019 12:46

Friday broker round-up

(Sharecast News) - Bakkavor Group: Berenberg downgrades to sell with a target price of 105p.

14 Mar 2019 14:16

Oxford Biomedica swings to positive earnings in 2018

(Sharecast News) - Gene and cell therapy group Oxford Biomedica reported a 72% increase in gross income in its preliminary results for the year ended 31 December on Thursday, to £67.9m.

Latest Share Chat

Oxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Oxford Biomedica says Sanofi pulling out of haemophilia project

Login to your account

Quickpicks are a member only feature

Login to your account